Walter Eisner • Wed, November 19th, 2014
The first patient is enrolled in Zyga Technology, Inc.’s facet DUET clinical study.
The company announced on November 11, 2014 that Reginald Davis, M.D. FACS, Chief of Neurosurgery at Greater Baltimore Medical Center, performed the first surgery in the study, a multi-site, single-arm study of the Zyga Glyder facet restoration device in subjects with lumbar facet pain syndrome. The study will be performed at five sites and will include up to 20 patients.
Davis said the device “fills a significant gap in the care continuum for facet joint pain. “When conservative treatments such as facet injection or rhizotomy fail to provide relief for these patients, our only recourse has been to perform a fusion, a procedure that eliminates motion and permanently alters the natural movement of the spine. The Glyder Device is designed to provide long-term relief of facet joint pain through a non-fusion procedure that preserves surrounding anatomy and future treatment options.”
The company says that 30% of all chronic low back pain derives from the facet joint.
The device consists of two small polymer discs that cover the articulating surfaces of the facet joint.
CE Mark and Financing